Published in Oncotarget on August 09, 2016
HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 6.23
Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev (2004) 5.66
HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol (2010) 5.65
The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep (2002) 4.76
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature (2012) 4.41
Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology (2005) 4.09
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med (2012) 2.89
Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med (2012) 2.79
The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol (2013) 2.22
HMGB1 in cancer: good, bad, or both? Clin Cancer Res (2013) 1.79
30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem (1991) 1.46
Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. J Leukoc Biol (2009) 1.45
Regulation of cell migration by amphoterin. J Cell Sci (2000) 1.41
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest (2014) 1.35
Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem Biophys Res Commun (2007) 1.30
Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma. J Cancer Res Clin Oncol (2009) 1.26
A Janus tale of two active high mobility group box 1 (HMGB1) redox states. Mol Med (2012) 1.21
Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosomes Cancer (2010) 1.14
Rage signalling promotes intestinal tumourigenesis. Oncogene (2012) 1.11
Wnt signalling in the mouse intestine. Oncogene (2006) 1.08
HMGB1: roles in base excision repair and related function. Biochim Biophys Acta (2010) 1.07
High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J Biol Chem (2014) 1.03
Diagnostic significance of serum HMGB1 in colorectal carcinomas. PLoS One (2012) 0.97
Native versus recombinant high-mobility group B1 proteins: functional activity in vitro. Inflammation (2004) 0.92
Oxidative stress-mediated HMGB1 biology. Front Physiol (2015) 0.87
The human HMGB1 promoter is modulated by a silencer and an enhancer-containing intron. Biochim Biophys Acta (2001) 0.87
High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A. Oncogene (2013) 0.85
New perspectives on β-catenin control of cell fate and proliferation in colon cancer. Food Chem Toxicol (2014) 0.82
Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death Dis (2015) 0.81
Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC). Biochem Biophys Res Commun (2013) 0.80
A functional connectome: regulation of Wnt/TCF-dependent transcription by pairs of pathway activators. Mol Cancer (2015) 0.80
Hunk/Mak-v is a negative regulator of intestinal cell proliferation. BMC Cancer (2015) 0.79
Non-histone protein HMGB1 inhibits the repair of damaged DNA by cisplatin in NIH-3T3 murine fibroblasts. BMB Rep (2016) 0.77